Multiple Oral Doses Of PH-797804 In Healthy Japanese Adult Subjects

APhase 1, Placebo-Controlled, Randomized, Parallel Group, Subject- And Investigator-Blind, Sponsor-Open Study To Assess The Safety, Tolerability, And Pharmacokinetics Of PH-797804 Following Multiple Escalating Oral Doses In Healthy Japanese Adult Subjects

Study A6631027 will evaluate the safety, tolerability and pharmacokinetics of PH-797804 when administered to healthy Japanese subjects once a day (QD) for 10 days.

Inclusion Criteria:

• Healthy Volunteers
• Japanese

Exclusion Criteria:

• Subjects with clinically significant skin lesions
• Subjects with known tuberculosis infection